Literature DB >> 17006579

Diabetic retinopathy in type II diabetics detected by targeted screening versus newly diagnosed in general practice.

Swati Agarwal1, Rajiv Raman, Rani Padmaja Kumari, Himanshu Deshmukh, Pradeep G Paul, Perumal Gnanamoorthy, Govindasamy Kumaramanickavel, Tarun Sharma.   

Abstract

INTRODUCTION: The aim of this study was to compare the occurrence of diabetic retinopathy in targeted screening diabetic patients (Group I) with newly diagnosed diabetic patients in general practice (Group II).
MATERIALS AND METHODS: This was an observational cross-sectional study. Data were obtained from 25,313 subjects who participated in the diabetic screening camps, and 128 newly diagnosed diabetes who presented to the diabetic retinopathy screening camps in general practice in rural and urban south India. The study variables were collected from all patients who underwent eye examination from the target screening detected diabetics [(n = 173) Group I] and those newly diagnosed in general practice [(n = 128) Group II]. The variations in prevalence of diabetic retinopathy and sight-threatening diabetic retinopathy in Group I and Group II and the factors affecting it were identified.
RESULTS: The occurrence of diabetic retinopathy was 6.35% (95% CI, 2.5-9.5) in Group I and 11.71% (95% CI, 5.6-16.4) in Group II. No significant difference was observed on occurrence of diabetic retinopathy, including sightthreatening retinopathy, in rural versus urban population and in Group I versus Group II. Patients diagnosed in general practice (Group II) with systolic blood pressure (BP) >140 were more likely to have retinopathy (P = 0.02).
CONCLUSIONS: Diabetic retinopathy including sightthreatening complications was found at the time of diagnosis of diabetes in the targeted screening group as well as in newly diagnosed diabetics in the general practice group.

Entities:  

Mesh:

Year:  2006        PMID: 17006579

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  7 in total

1.  Prevalence of Diabetic Retinopathy and its Associated Factors in a Rural Area of Villupuram District of Tamil Nadu, India.

Authors:  Balasubramanian Nadarajan; Ganesh Kumar Saya; Ramesh Babu Krishna; Subitha Lakshminarayanan
Journal:  J Clin Diagn Res       Date:  2017-07-01

2.  Achutha Menon Centre Diabetes Risk Score: a type 2 diabetes screening tool for primary health care providers in rural India.

Authors:  Thirunavukkarasu Sathish; Srinivasan Kannan; P Sankara Sarma; Kavumpurathu Raman Thankappan
Journal:  Asia Pac J Public Health       Date:  2012-08-02       Impact factor: 1.399

3.  Prevalence and associated factors of diabetic retinopathy in rural Korea: the Chungju metabolic disease cohort study.

Authors:  Ji-Hyun Kim; Hyuk-Sang Kwon; Yong-Moon Park; Jin-Hee Lee; Man-Soo Kim; Kun-Ho Yoon; Won Chul Lee; Bong-Yun Cha; Ho-Young Son
Journal:  J Korean Med Sci       Date:  2011-07-30       Impact factor: 2.153

4.  Evaluation of multiple risk factors involved in the development of Diabetic Retinopathy.

Authors:  Syeda Birjees Anwar; Naveed Asif; Syed Abid Hassan Naqvi; Sidra Malik
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

5.  Early Screening for Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes and Its Effectiveness in Terms of Morbidity and Clinical Treatment: A Nationwide Population-Based Cohort.

Authors:  Yu-Chien Chung; Ting Xu; Tao-Hsin Tung; Mingchih Chen; Pei-En Chen
Journal:  Front Public Health       Date:  2022-04-26

6.  Prevalence and risk factors of diabetic retinopathy among Jordanian patients with type 2 diabetes.

Authors:  Rasmieh M Al-Amer; Yousef Khader; Samer Malas; Nakhleh Abu-Yaghi; Muawyah Al-Bdour; Kamel Ajlouni
Journal:  Digit J Ophthalmol       Date:  2008-08-04

7.  Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.

Authors:  G Bhanuprakash Reddy; A Satyanarayana; N Balakrishna; Radha Ayyagari; M Padma; K Viswanath; J Mark Petrash
Journal:  Mol Vis       Date:  2008-03-24       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.